CIK 0001737287
- Non-accelerated filer
- Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823562771
- Phone
- +1 650-457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-16 | Chang David D President and CEO | Sale | −47,763 | $2.47 | $118K | 5,150,599 |
| 2026-02-02 | Chang David D President and CEO | Sale | −95,269 | $1.80 | $171K | 5,185,862 |
| 2026-02-02 | Chang David D President and CEO | Grant or award · Stock Option (Right to buy) | +1,387,931 | 1,387,931 | ||
| 2026-02-02 | Chang David D President and CEO | Grant or award · Restricted Stock Unit | +392,586 | 392,586 | ||
| 2025-03-14 | Chang David D President and CEO | Sale | −46,668 | $1.96 | $91K | 5,276,569 |
| 2025-02-03 | Chang David D President and CEO | Sale | −46,003 | $1.68 | $77K | 5,317,237 |
| 2025-01-24 | Chang David D President and CEO | Grant or award | +552,174 | 5,363,240 | ||
| 2025-01-24 | Chang David D President and CEO | Grant or award · Stock Option (Right to buy) | +1,952,130 | 1,952,130 | ||
| 2024-05-16 | Chang David D President and CEO | Grant or award | +344,828 | $2.90 | $1.0M | 4,810,106 |
| 2024-03-14 | Chang David D President and CEO | Shares withheld for taxes | −53,393 | $4.33 | $231K | 4,465,278 |
| 2024-01-25 | Chang David D President and CEO | Grant or award | +317,800 | 4,513,203 | ||
| 2024-01-25 | Chang David D President and CEO | Grant or award · Stock Option (Right to buy) | +1,123,535 | 1,123,535 | ||
| 2023-03-22 | Chang David D President and CEO | Grant or award | +1,924,464 | 4,193,911 | ||
| 2023-03-22 | Chang David D President and CEO | Grant or award · Stock Option (Right to Buy) | +1,492,200 | 1,492,200 | ||
| 2023-03-14 | Chang David D President and CEO | Shares withheld for taxes | −22,340 | $5.56 | $124K | 2,269,447 |
| 2022-03-23 | Chang David D President and CEO | Grant or award · Stock Option (Right to Buy) | +2,195,512 | 2,195,512 | ||
| 2022-03-15 | Chang David D President and CEO | Sale | −23,648 | $7.65 | $181K | 2,289,652 |
| 2021-05-24 | Chang David D President and CEO | Option exercise | +27,410 | $18.22 | $499K | 2,312,279 |
| 2021-05-24 | Chang David D President and CEO | Option exercise · Stock Option (Right to Buy) | −27,410 | 541,190 | ||
| 2021-03-26 | Chang David D President and CEO | Grant or award | +80,452 | 2,284,869 |
Page 1 of 3 · 52 trades